Research programme: antifungals - Dorlin

Drug Profile

Research programme: antifungals - Dorlin

Alternative Names: AJ-V-6D; Antifungals research programme - Dorlin; DP 214; Fatty acid synthase inhibitors research programme - Dorlin; Research programme: fatty acid synthase inhibitors - Dorlin

Latest Information Update: 28 Nov 2002

Price : $50

At a glance

  • Originator Dorlin Pharmaceuticals; Nonindustrial source
  • Class
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Mycoses

Most Recent Events

  • 28 Nov 2002 No development reported - Preclinical for Mycoses in USA (unspecified route)
  • 12 Oct 2000 Preclinical development for Mycoses in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top